Zhejiang Huaye Plastics Machinery
301616
Alnera Aluminium
301613
Tibet Duo Rui Pharmaceutical
301075
4
ChengDu Sheng Nuo Biotec
688117
5
Shenzhen Kaifa Technology
920029
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -6.38%429.62M | -15.94%107.02M | -15.49%102.42M | 3.50%101.32M | 5.66%118.87M | 24.16%458.9M | 48.52%127.32M | 36.66%121.19M | -1.18%97.89M | 17.03%112.5M |
Operating revenue | -7.39%395.87M | -14.80%99.37M | -17.00%92.26M | 0.00%93.17M | 4.26%111.08M | 27.76%427.48M | 46.22%116.62M | 41.70%111.16M | 3.62%93.17M | 23.19%106.53M |
Cost of revenue | -5.76%316.61M | -12.68%80.32M | -9.27%76.26M | 2.27%76.98M | -1.91%83.06M | 19.97%335.97M | 40.94%91.98M | 27.74%84.05M | -4.99%75.27M | 21.39%84.68M |
Gross profit | -8.08%113.01M | -24.45%26.7M | -29.58%26.16M | 7.56%24.34M | 28.72%35.81M | 37.27%122.94M | 72.70%35.34M | 62.31%37.14M | 14.03%22.63M | 5.51%27.82M |
Operating expense | 31.87%55.56M | 38.64%14.19M | 11.90%12.42M | 31.00%14.16M | 48.04%14.79M | -6.25%42.14M | -21.00%10.24M | 29.80%11.1M | 3.24%10.81M | -22.94%9.99M |
Selling and administrative expenses | 31.87%55.56M | 38.64%14.19M | 11.90%12.42M | 31.00%14.16M | 48.04%14.79M | -6.25%42.14M | -21.00%10.24M | 29.80%11.1M | 3.24%10.81M | -22.94%9.99M |
-General and administrative expense | 31.87%55.56M | 38.64%14.19M | 11.90%12.42M | 31.00%14.16M | 48.04%14.79M | -6.25%42.14M | -21.00%10.24M | 29.80%11.1M | 3.24%10.81M | -22.94%9.99M |
Operating profit | -28.90%57.45M | -50.17%12.51M | -47.26%13.74M | -13.89%10.18M | 17.89%21.03M | 81.10%80.8M | 234.51%25.11M | 81.71%26.05M | 26.09%11.82M | 33.01%17.83M |
Net non-operating interest income expense | 18.00%-115.45M | 44.51%-20.43M | 25.62%-25.71M | 10.57%-31.46M | -10.59%-37.85M | -37.41%-140.78M | -29.29%-36.82M | -38.65%-34.57M | -41.34%-35.18M | -41.63%-34.22M |
Non-operating interest expense | -18.00%115.45M | -44.51%20.43M | -25.62%25.71M | -10.57%31.46M | 10.59%37.85M | 37.41%140.78M | 29.29%36.82M | 38.65%34.57M | 41.34%35.18M | 41.63%34.22M |
Other net income (expense) | 328.42%91.5M | -324.11%-12.31M | -444.83%-42.99M | -381.76%-7.43M | 4,846.85%139.32M | 125.60%21.36M | 57.64%-2.9M | 516.71%12.47M | 103.28%2.64M | -143.39%-2.94M |
Gain on sale of security | 125.52%4.13M | 205.63%3.19M | -190.13%-2.57M | -71.85%920K | 303.46%2.59M | -88.85%1.83M | -3,823.38%-3.02M | -48.33%2.86M | -16.97%3.27M | -118.11%-1.27M |
Earnings from equity interest | -28.47%24.2M | -62.10%4.37M | -51.91%4.91M | ---- | ---- | --33.83M | --11.53M | --10.21M | ---- | ---- |
Special income (charges) | 488.97%58.99M | -84.58%-21.28M | -16,095.42%-46M | -540.26%-10.48M | 8,059.43%136.74M | 84.81%-15.17M | -70.12%-11.53M | 96.67%-284K | 98.06%-1.64M | -553.23%-1.72M |
-Less:Restructuring and merger&acquisition | 696.95%31.12M | 2,974.61%17.93M | 564.76%2.09M | 171.90%3.27M | 334.09%7.83M | -43.96%3.91M | -88.83%583K | -79.24%315K | 9,353.85%1.2M | 633.33%1.8M |
-Less:Impairment of capital assets | 12,540.74%68.26M | 281.18%324K | --0 | -95.60%20K | --67.92M | -99.41%540K | --85K | --0 | -99.46%455K | --0 |
-Less:Other special charges | 357.98%50.08M | --2.88M | --42.24M | --4.96M | ---- | --10.93M | ---- | ---- | ---- | ---- |
-Gain on sale of business | 443,606.38%208.45M | -7,450.00%-151K | -18,477.78%-1.67M | -3,959.26%-2.19M | 1,180,250.00%212.46M | 97.30%-47K | 99.88%-2K | 89.41%-9K | ---54K | --18K |
-Gain on sale of property,plant,equipment | -100.38%-1K | --0 | -85.00%6K | -145.33%-34K | -60.29%27K | -48.72%260K | -21.43%77K | -59.60%40K | -76.04%75K | 2,366.67%68K |
Other non- operating income (expenses) | 384.16%4.19M | 1,089.83%1.4M | 311.43%666K | 111.83%2.13M | -123.21%-13K | 21,725.00%865K | --118K | ---315K | 25,250.00%1.01M | --56K |
Income before tax | 186.74%33.5M | -38.44%-20.23M | -1,493.01%-54.97M | -38.56%-28.71M | 733.92%122.5M | 72.66%-38.63M | 47.47%-14.62M | 129.04%3.95M | 78.39%-20.72M | -384.31%-19.32M |
Income tax | 45,452.17%146.68M | 806.18%4.55M | 197,918.06%142.57M | -654K | 183.33%210K | -0.92%322K | 2,688.89%502K | 205.88%72K | 0 | -604.00%-252K |
Earnings from equity interest net of tax | ---- | ---- | ---- | -40.41%4.28M | 116.70%10.64M | ---- | ---- | ---- | 63.49%7.18M | 21.66%4.91M |
Net income | -190.59%-113.18M | -63.93%-24.78M | -5,199.15%-197.54M | -75.61%-23.78M | 1,038.55%132.93M | 68.45%-38.95M | 36.65%-15.12M | 149.74%3.87M | 85.25%-13.54M | -283,160.00%-14.16M |
Net income continuous Operations | -190.59%-113.18M | -63.93%-24.78M | -5,199.15%-197.54M | -75.61%-23.78M | 1,038.55%132.93M | 68.45%-38.95M | 36.65%-15.12M | 149.74%3.87M | 85.25%-13.54M | -283,160.00%-14.16M |
Minority interest income | ||||||||||
Net income attributable to the parent company | -190.59%-113.18M | -63.93%-24.78M | -5,199.15%-197.54M | -75.61%-23.78M | 1,038.55%132.93M | 68.45%-38.95M | 36.65%-15.12M | 149.74%3.87M | 85.25%-13.54M | -283,160.00%-14.16M |
Preferred stock dividends | -7.56%22.32M | -89.01%752K | 11.66%7.4M | 59.41%6.99M | 472.48%24.15M | -1.82%6.84M | 26.47%6.63M | 24.60%6.3M | 133.62%4.39M | |
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | -114.75%-135.5M | -16.29%-25.54M | -7,344.28%-204.94M | -19.88%-23.78M | 778.98%125.94M | 50.58%-63.09M | 28.78%-21.96M | 78.87%-2.75M | 79.52%-19.84M | -242.28%-18.55M |
Basic earnings per share | -109.17%-12.78 | -13.21%-2.4 | -7,029.63%-19.25 | -52.36%-2.91 | 762.09%12.05 | 51.93%-6.11 | 30.03%-2.12 | 78.91%-0.27 | 79.96%-1.91 | -234.81%-1.82 |
Diluted earnings per share | -109.17%-12.78 | -13.21%-2.4 | -7,029.63%-19.25 | -52.36%-2.91 | 730.22%11.47 | 51.93%-6.11 | 30.03%-2.12 | 78.91%-0.27 | 79.96%-1.91 | -237.88%-1.82 |
Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |